ExoLuminate: An observational registry study for detection of pancreatic adenocarcinoma (PDAC) in high-risk or clinically suspicious patients

• Published in: Journal of clinical oncology Vol. 41; no. 16_suppl; p. TPS4203
• Main Authors: Hinestrosa, Juan Pablo, Izaguirre Carbonell, Jesus, Balcer, Heath, Kurzrock, Razelle, Billings, Paul R.
• Format: Journal Article
• Language: English
• Published: American Society of Clinical Oncology 01.06.2023

TPS4203Background: The detection of pancreatic ductal adenocarcinoma (PDAC) at early-stages is critical to improving patient survival. However, the lack of a clinically useful biomarker assay poses a challenge for earlier detection. A liquid biopsy test (ExoVita Pancreas) which uses extracellular ve...